AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 186 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $171 | +6.2% | 21,974 | +31.8% | 0.01% | +12.5% |
| Q2 2023 | $161 | -16.1% | 16,674 | -4.8% | 0.01% | -11.1% |
| Q1 2023 | $192 | +84.6% | 17,510 | -27.2% | 0.01% | +80.0% |
| Q4 2022 | $104 | -99.9% | 24,066 | -12.1% | 0.01% | -58.3% |
| Q3 2022 | $205,000 | -15.3% | 27,377 | +13.6% | 0.01% | -7.7% |
| Q2 2022 | $242,000 | -18.2% | 24,091 | +1.0% | 0.01% | 0.0% |
| Q1 2022 | $296,000 | -58.4% | 23,847 | -23.4% | 0.01% | -53.6% |
| Q4 2021 | $712,000 | +118.4% | 31,135 | +111.3% | 0.03% | +100.0% |
| Q3 2021 | $326,000 | +288.1% | 14,736 | +128.6% | 0.01% | +250.0% |
| Q2 2021 | $84,000 | 0.0% | 6,447 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $84,000 | -7.7% | 6,447 | -2.0% | 0.00% | -20.0% |
| Q4 2020 | $91,000 | -8.1% | 6,576 | -2.3% | 0.01% | -16.7% |
| Q3 2020 | $99,000 | -9.2% | 6,732 | +0.3% | 0.01% | -25.0% |
| Q2 2020 | $109,000 | +9.0% | 6,710 | -3.1% | 0.01% | 0.0% |
| Q1 2020 | $100,000 | – | 6,926 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |